ADC Therapeutics

New Providence,  NJ 
United States
  • Booth: 632

Navigate a path to response in 3L DLBCL— see our data

Confronting cancer with the full potential of our science.

ADC Therapeutics is a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation, targeted antibody drug conjugates (ADCs). ADC Therapeutics is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Brands: ZYNLONTA® (loncastuximab tesirine-lpyl)


Contact the Tandem Meetings of ASTCT & CIBMTR Office at

For Technical Support with this webpage, please contact support.